Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Adamis, Aeterna Zentaris, Affinity, Altimmune, Astrazeneca, Aveo, Betterlife, Biodextris, Biontech, Biovaxys, Blanver, BPS, Canbridge, Cocrystal, Complix, Cytoagents, Dotbio, ERS Genomics, Exevir, Farmacore, Formosa, Genevant, Genome and Co., Greenlight, Hepatx, Hitgen, I-Mab, Immunitybio, Immunoscape, Insilico, Johnson & Johnson, Lipigon, Medolife, Merck, Namocell, Neuren, Oragenics, PDS, Persephone, Pfizer, Resverlogix, Setsuro, Sorrento, Sosei, Takara, Takeda, Tevogen, TFF, Translate, UCB, Uni-Bio, Valo, VBI Vaccines, Wuxi Apptec.